株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医療用電極の世界市場:成長、動向、および予測(2019年~2024年)

Medical Electrodes Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 661043
出版日 ページ情報 英文 125 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
医療用電極の世界市場:成長、動向、および予測(2019年~2024年) Medical Electrodes Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年09月01日 ページ情報: 英文 125 Pages
概要

世界の医療用電極市場は、心血管疾患および神経疾患の有病率の増加、バイオ医薬品企業による技術進歩への投資の増加、低侵襲手術への注目の高まりなどの要因によって推進される見込みです。

当レポートは世界の医療用電極市場について調査しており、市場機会や動向、成長および阻害要因、製品タイプ・ユーザービリティ・モダリティタイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
    • 心血管疾患および神経疾患の有病率の増加
    • バイオ医薬品企業別技術進歩のための投資の増加
    • 低侵襲手術への注目の高まり
  • 阻害要因
    • 医療用電極との生体適合性の問題
    • 医療電極に関連する厳しい規制ガイドライン
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • 製品タイプ別
    • 表面電極
    • 針電極
  • ユーザービリティ別
    • 使い捨て医療電極
    • 再利用可能な医療用電極
  • モダリティタイプ別
    • 心電図(ECG)
    • 脳波検査(EEG)
    • 筋電図(EMG)
    • 脳幹聴覚誘発電位(BAEPS)
    • その他
  • 用途別
    • 循環器
    • 神経生理学
    • 睡眠障害
    • 術中モニタリング
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • 3M
    • 3M
    • Ambu A/S
    • Cognionics Inc.
    • CONMED Corporation
    • Cooper Surgical Inc.
    • Dymedix
    • Koninklijke Philips NV
    • Medtronic Plc
    • Natus Medical Incorporated
    • 日本光電工業株式会社

第7章 市場機会および今後の動向

目次
Product Code: 60466

Market Overview

The market for medical electrodes is being driven by factors such as the increasing prevalence of cardiovascular and neurological diseases, increasing investment for technological advancements by biopharmaceutical companies and rising focus towards minimally invasive surgeries.

The rising population of the world is stimulating the demand for increased access and advancements in healthcare treatments. Due to the aging and rising world population, the demand for healthcare products and services has increased by multiple times in the past decade, particularly in the developed and high-economic growth countries. The growing prevalence of cardiac and neurological diseases plays an essential role in the growth of the medical electrodes market.

According to an article published in 2017, by the American College of Cardiology, the occurrence rate of cardiovascular disease was around 422.7 million cases, by 2015. The lowest prevalence was in the countries in the Asia-Pacific region, followed by a higher prevalence in developed markets, such as the United States, Germany, and the United Arab Emirates. The highest prevalence was in low-economic, developing countries, such as the Sub-Saharan countries. In the case of ischemic heart diseases (IHD), there are around nine million deaths, making it one of the leading causes of death, globally.

Neurological diseases are one among the major diseases, prevalent in the world. There are over 1,000 disorders of the nervous system, including cerebrovascular disease, Alzheimer's and other dementias, migraine, epilepsy, tetanus, meningitis, Parkinson's disease, multiple sclerosis, and poliomyelitis, among others. Hence, as per the above-mentioned statements, it is indicated that the market studied will grow in the coming future.

Scope of the Report

The electrodes in medical devices transfer the ionic current energy into electric current, in the body, through surface quantification of ionic currents. These currents are further amplified and studied, and help in the diagnosis of diseases. The electrodes for medical purposes are made up of lead, metal, and electrode conducting paste.

Key Market Trends

Cardiovascular Applications are Believed to Witness Highest CAGR Over the Forecast Period

Cardiovascular diseases belong to the class of disease, which involves the heart and blood vessels, and is related to atherosclerosis. Coronary artery disease (CAD), myocardial infarction, arrhythmia, heart failure, congenital heart defects, cardiomyopathy, and peripheral artery disease are among the most common cardiovascular diseases.

As per the World Health Organization (WHO), approximately 17.7 million people die every year from cardiovascular diseases, resulting in 31% of the global deaths. As per the WHO, in the European region, more than half of all the deaths occur due to cardiovascular diseases. Along with that, the prevalence of CVD and hypertension has been observed as rapidly increasing in the Sub-Saharan, African, and other developing markets. There are nearly 150 clinical trials registered involving medical electrodes devices for cardiovascular diseases application, attracting a large number of research centers, companies, and universities, as sponsors and collaborators.

Ambu, CONMED, and Natus Medical are among the major companies that have a substantial business segment related to medical electrodes, for neurological and cardiological examinations. Graphene-based dry ECG electrode and portable wireless ECG measurement system have more demand for applications in various cardiac diseases. With an increasing demand for better treatment of cardiovascular diseases, the medical electrodes demand is expected to rise at a high rate.

North America Dominates the Market

The United States holds the largest shares in the market studied, due to better healthcare infrastructure, effective government policies, a huge base of multinational companies, and high awareness among people, about testing and testing devices in healthcare.

The prevalence of certain chronic inflammatory disorders, such as cardiovascular diseases, diabetes, IBDs, and others, are high, as compared to other chronic indications. For cardiovascular diseases, according to an article published in 2017, in healthy people, more than one in three adults are affected by heart diseases. Along with that, heart diseases and strokes cost more than USD 500 billion, each year. Medical electrodes come in the class II category, under the US Food and Drug Administration (FDA), as they are mostly used for surgical purposes.

In the United States, medical reimbursement policies include major medical electrodes, which augment the growth of the market studied. The reimbursement policies in the country are much more supportive, regarding the use of medical devices.

Owing to all these factors, the market studied is expected to grab the largest share in the United States.

Competitive Landscape

The market for medical electrodes is moderately competitive and consists of the global as well as local players. However, a major share of the market is gained by global players only. Due to the rising spread of cardiovascular and neurological diseases across the globe, companies are coming up with the novel products to cater the consumers across different geographies.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular and Neurological Diseases
    • 4.2.2 Increasing Investment for Technological Advancement by Biopharmaceutical Companies
    • 4.2.3 Rising Focus toward Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Biocompatibility Issues with Medical Electrodes
    • 4.3.2 Stringent Regulatory Guidelines Associated with Medical Electrodes
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Surface Electrodes
    • 5.1.2 Needle Electrodes
  • 5.2 By Usability
    • 5.2.1 Disposable Medical Electrodes
    • 5.2.2 Reusable Medical Electrodes
  • 5.3 By Modality Type
    • 5.3.1 Electrocardiography (ECG)
    • 5.3.2 Electroencephalography (EEG)
    • 5.3.3 Electromyography (EMG)
    • 5.3.4 Brainstem Auditory Evoked Potentials (BAEPS)
    • 5.3.5 Other Modality Types
  • 5.4 By Application
    • 5.4.1 Cardiology
    • 5.4.2 Neurophysiology
    • 5.4.3 Sleep Disorders
    • 5.4.4 Intraoperative Monitoring
    • 5.4.5 Other Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 US
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 UK
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Ambu A/S
    • 6.1.3 Cognionics Inc.
    • 6.1.4 CONMED Corporation
    • 6.1.5 Cooper Surgical Inc.
    • 6.1.6 Dymedix
    • 6.1.7 Koninklijke Philips NV
    • 6.1.8 Medtronic Plc
    • 6.1.9 Natus Medical Incorporated
    • 6.1.10 Nihon Kohden Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top